Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $269.45 | Total: $1,347.25 |
| 1 | 10 | $228.24 | Total: $2,282.40 |
| 1 | 25 | $193.37 | Total: $4,834.25 |
| 1 | 50 | $164.84 | Total: $8,242.00 |
| 1 | 100 | $142.65 | Total: $14,265.01 |
Overview
Rovatirelin (S-0373) is a newly synthesized thyrotropin-releasing hormone (TRH) analog that ameliorates cytosine arabinoside-induced motor dysfunction in a rat model of spinal cerebellar degeneration via acetylcholine and dopamine neurotransmission.
Chemical Properties
| Molecular Formula | C16H22N4O4S |
| Molecular Weight | 366.43 |
| CAS Numbers | 204386-76-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@@H](C(=O)N1[C@H](C)CCC1)(CC2=CSC=N2)NC(=O)[C@@H]3[C@H](C)OC(=O)N3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Ijiro T, et al. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission. Clin Exp Pharmacol Physiol. 2022 Sep;49[9] 950-958.